In addition to extensive current applications, AgraTech is seeking to expand the reach of this all natural product. For a variety of functions, from military to medicinal, AgraTech research & collaboration is leading. Learn more about AgraTech by exploring our:

AgraTech has filed a provisional patent on a sprayable hemostatic agent designed to treat submucosal bleeding in the nose, the gastrointestinal tract and other areas. The technology is currently in development.

Other disclosures, including agricultural and medical applications, are in preparation or are being evaluated for patentability. AgraTech has entered into an agreement with SC Department of Natural Resources to transfer biotech shrimp farming technology to the company. A beta site is presently being developed in Williamsburg County, SC.

For more details, phone: (877) 460-5510

AgraTech International has developed a biotech enterprise focused on chitosan, a biomaterial processed from crustacean shells (shrimp, crawfish, crab, etc.).

AgraTech will be the only commercial manufacturer of chitosan in the United States.

Demand for chitosan is outpacing supply as new uses for are being discovered and new chitosan-based products are developed.